Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease
Tài liệu tham khảo
ACTIVE Writing Group of the ACTIVE Investigators, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): a randomised controlled trial, Lancet, 367, 1903, 10.1016/S0140-6736(06)68845-4
ACTIVE Investigators, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N. Engl. J. Med., 360, 2066, 10.1056/NEJMoa0901301
Kannel, 1982, Epidemiologic features of chronic atrial fibrillation: the Framingham study, N. Engl. J. Med., 306, 1018, 10.1056/NEJM198204293061703
Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham heart study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946